Francis Christopher's most recent trade in Wave Life Sciences Ltd. was a trade of 17,900 Ordinary Shares done at an average price of $3.9 . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 26 Feb 2026 | 17,900 | 79,767 (0%) | 0% | 3.9 | 69,273 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 17,900 | 143,200 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 26 Feb 2026 | 17,900 | 61,867 (0%) | 0% | 15.1 | 270,183 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 15,294 | 61,175 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 26 Feb 2026 | 15,294 | 61,867 (0%) | 0% | 15 | 229,410 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 26 Feb 2026 | 15,294 | 77,161 (0%) | 0% | 4.8 | 72,647 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 232,500 | 232,500 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 38,750 | 63,750 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 05 Feb 2026 | 1,883 | 61,867 (0%) | 0% | 13.4 | 25,326 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 02 Jan 2026 | 9,375 | 34,375 (0%) | 0% | 3.1 | 29,438 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 9,375 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 15.92 per share. | 02 Jan 2026 | 8,080 | 26,295 (0%) | 0% | 15.9 | 128,634 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 02 Jan 2026 | 1,295 | 25,000 (0%) | 0% | 16.7 | 21,627 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 168,231 | 76,469 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 125,300 | 161,100 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.19 per share. | 08 Dec 2025 | 122,349 | 25,000 (0%) | 0% | 14.2 | 1,736,744 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Dec 2025 | 122,349 | 147,349 (0%) | 0% | 4.8 | 581,158 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 08 Dec 2025 | 107,400 | 25,000 (0%) | 0% | 14.6 | 1,563,314 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 08 Dec 2025 | 107,400 | 132,400 (0%) | 0% | 3.9 | 415,638 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 75,000 | 9,375 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 08 Dec 2025 | 50,000 | 25,000 (0%) | 0% | 16 | 800,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.48 per share. | 08 Dec 2025 | 50,000 | 75,000 (0%) | 0% | 10.5 | 524,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 50,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.50 per share. | 08 Dec 2025 | 45,882 | 25,000 (0%) | 0% | 14.5 | 665,289 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Dec 2025 | 45,882 | 70,882 (0%) | 0% | 4.8 | 217,940 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 08 Dec 2025 | 37,500 | 25,000 (0%) | 0% | 14.1 | 528,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 08 Dec 2025 | 37,500 | 62,500 (0%) | 0% | 3.1 | 117,750 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.50 per share. | 08 Dec 2025 | 28,125 | 25,000 (0%) | 0% | 14.5 | 407,813 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 08 Dec 2025 | 28,125 | 53,125 (0%) | 0% | 3.1 | 88,313 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 08 Dec 2025 | 22,500 | 25,000 (0%) | 0% | 14.1 | 316,800 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.83 per share. | 08 Dec 2025 | 22,500 | 47,500 (0%) | 0% | 2.8 | 63,675 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 22,500 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 17,900 | 25,000 (0%) | 0% | 15 | 268,500 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 08 Dec 2025 | 17,900 | 42,900 (0%) | 0% | 3.9 | 69,273 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 9,375 | 25,000 (0%) | 0% | 15 | 140,625 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 08 Dec 2025 | 9,375 | 34,375 (0%) | 0% | 3.1 | 29,438 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 151,000 | 151,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.17 per share. | 08 Nov 2024 | 36,000 | 36,000 (0%) | 0% | 8.2 | 294,120 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 08 Nov 2024 | 36,000 | 0 (0%) | 0% | 16 | 576,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 36,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 16 Oct 2024 | 79,714 | 0 (0%) | 0% | 14 | 1,115,996 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 65,625 | 84,375 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.75 per share. | 16 Oct 2024 | 65,625 | 0 (0%) | 0% | 13.8 | 902,344 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 16 Oct 2024 | 65,625 | 65,625 (0%) | 0% | 3.1 | 206,063 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 16 Oct 2024 | 40,997 | 0 (0%) | 0% | 13 | 532,961 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 40,997 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 16 Oct 2024 | 40,997 | 40,997 (0%) | 0% | 2.5 | 101,673 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 16 Oct 2024 | 22,500 | 0 (0%) | 0% | 13.5 | 303,750 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.83 per share. | 16 Oct 2024 | 22,500 | 22,500 (0%) | 0% | 2.8 | 63,675 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 22,500 | 22,500 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Francis Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 286,400 | 286,400 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 244,700 | 244,700 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 16 Feb 2023 | 10,258 | 79,714 (0%) | 0% | 4.0 | 41,340 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 45,000 | 45,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 32,500 | 100,839 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 04 May 2022 | 10,867 | 89,972 (0%) | 0% | 1.7 | 18,691 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 16 Feb 2022 | 10,123 | 68,339 (0%) | 0% | 2.3 | 23,384 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 150,000 | 150,000 | - | - | Share Option (right to buy) |